Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01696331 · ClinicalTrials.gov registry record · NA
Text Messaging for Adherence in Adolescent Liver Transplant Recipients
A NA study of Liver Transplant and Adherence, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
- 1
- Study location
NCT01696331: Completed NA study of Liver Transplant and Adherence, sponsored by Stanford University.
NCT01696331 is a NA study of Liver Transplant and Adherence that has completed, run by Stanford University. The registered enrollment target is 42 participants, below the 5,456-participant average among 19 other Liver Transplant trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01696331, a NA study of Liver Transplant and Adherence, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
Text message reminders will improve adherence to lab tests in adolescent liver transplant recipients.
Conditions Studied
Interventions
- BEHAVIORAL Text Message Reminder
Study Locations (1)
California
- Lucile Packard Children's Hospital - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2012-09 |
| Est. Completion | 2013-01 |
| Phase | NA |
What the finished NCT01696331 record still lists
NCT01696331 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 5,456-participant average among 19 other Liver Transplant trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Liver Transplant appearing as the primary indexed condition, and to 1 intervention - of which Text Message Reminder is the first listed.
NCT01696331 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01696331 about?
NCT01696331 is a clinical study titled "Text Messaging for Adherence in Adolescent Liver Transplant Recipients". Text message reminders will improve adherence to lab tests in adolescent liver transplant recipients.
What is the current status of trial NCT01696331?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2012-09. Estimated completion is 2013-01.
What conditions does trial NCT01696331 study?
This clinical trial studies the following conditions: Liver Transplant, Adherence.
What interventions are being tested in trial NCT01696331?
The interventions under investigation include: Text Message Reminder (BEHAVIORAL).
Who is sponsoring clinical trial NCT01696331?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01696331 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01696331's enrollment target sits among peer trials
42 15th of 19 higher than 5 of 19 other Liver Transplant trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Liver Transplant trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement
RECRUITING · NA
-
Normothermic Machine Perfusion of Steatotic Livers for Expansion of Donor Organ Pool
RECRUITING · NA
-
OCS Liver PROTECT Continued Access Protocol
COMPLETED · NA
-
Increasing Activity in Liver Transplant Patients
COMPLETED · NA
-
Expanding Liver Transplant Immunosuppression Minimization Via Everolimus
RECRUITING · Phase 2
-
US National OCS Liver Perfusion (OLP) Registry
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia